Calidi Biotherapeutics CLDI
NYSE CLDI
$0.67 -0.01 (-1.98%)
As of: Nov 11, 2026 · 2:54 PM EST

Calidi Biotherapeutics (CLDI) Revenue (2022 - 2025)

Updated

Calidi Biotherapeutics' Revenue came in at $45,000 for FY2022.

Analysis

Calidi Biotherapeutics (CLDI) Revenue (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 25.40 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 17.40 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 15.07 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 8.30 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 16.58 Bn
10 Calidi Biotherapeutics 991,199.98 -25.74 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -5,000.00
Sep 30, 2025 -10,000.00
Jun 30, 2025 -23,000.00
Mar 31, 2025 -38,000.00
Dec 31, 2024 -107,000.00
Sep 30, 2024 -134,000.00
Jun 30, 2024 -165,000.00
Mar 31, 2024 -155,000.00
Dec 31, 2023 -159,000.00
Sep 30, 2023 -223,000.00
Jun 30, 2023 2.20 Mn
Mar 31, 2023 -150,000.00
Sep 30, 2022 -21,000.00
API Access

Calidi Biotherapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=CLDI&period=max&api_key=YOUR_API_KEY